AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Informa PLC

Declaration of Voting Results & Voting Rights Announcements Jul 31, 2020

4915_rns_2020-07-31_7575ade5-b4b8-4f04-993c-eb5bc819b3ff.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8355U

Informa PLC

31 July 2020

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC

31 July 2020

Total Voting Rights

In accordance with rule 5.6.1R of the Financial Conduct Authority's ('FCA') Disclosure Guidance and Transparency Rules, Informa PLC (the 'Company') notifies the market that, as at 30 July 2020, the Company's issued share capital consisted of 1,502,137,804 ordinary shares of 0.1 pence each.  The Company does not hold any shares in Treasury.

Therefore, the total number of shares with voting rights in the Company is 1,502,137,804.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. 

Enquiries
Informa PLC

Heledd Hanscomb, Deputy Company Secretary
+44 (0)20 7017 5000

Informa PLC

Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRRBMFTMTMJBIM

Talk to a Data Expert

Have a question? We'll get back to you promptly.